Healthcare Industry News: GTCR
News Release - April 22, 2010
SV Life Sciences Adds Health Care Services Veteran Paul Wallace as Venture Partner
BOSTON--(HSMN NewsFeed)--SV Life Sciences ("SVLS") today announced the appointment of Paul Wallace, an executive with over 18 years of experience in health care services operations and private equity investing, as a Venture Partner. Mr. Wallace will be working on the SVLS health care services team.Mr. Wallace was most recently Senior Vice President of Healthways, Inc., a publicly held, Nashville-based provider of disease management, wellness and population health support solutions. His roles at Healthways included oversight of strategic planning, corporate development and sales & marketing. His leadership on acquisitions, joint ventures and strategic sales initiatives was instrumental in driving revenue from $120 million to $730 million. Prior to Healthways, Mr. Wallace was a senior investment officer at Petra Capital in Nashville, Gilbert Global Equity Partners (fka Soros Capital) in New York, Lazard Asia Investment Management in Singapore, and GTCR in Chicago. His principal investment experience includes more than 50 completed transactions representing over $1.3 billion of equity capital. He holds an MBA from the Kellogg School of Management at Northwestern University and a BA from the University of Richmond.
“We are very pleased to have Paul Wallace, a seasoned veteran of both the health care services and financial sectors, join the SVLS team as a Venture Partner,” said Darren Black, SVLS Partner. “Paul’s operations experience in growing a leading public health care service provider, coupled with his many years as a successful investment professional, will be a great asset to the SVLS health care services team.”
About SV Life Sciences
SV Life Sciences is a leading international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994. The SVLS team manages five venture capital funds and a publicly traded investment trust with approximately $2 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health care services. The SVLS health care services team is seeking to invest $5 million to $35 million in high growth, profitable health care services businesses with proven management teams. SVLS has offices in Boston, London and San Francisco. For more information, please visit the company’s website at http://www.svlsa.com.
Source: SV Life Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!